Merus (MRUS) News Today $46.58 -3.08 (-6.20%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Is Merus N.V. (MRUS) Top Performing European Stock Heading into 2025?November 13, 2024 | msn.comMerus (NASDAQ:MRUS) Shares Acquired by TimesSquare Capital Management LLCTimesSquare Capital Management LLC boosted its position in Merus (NASDAQ:MRUS - Free Report) by 49.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 272,435 shares of the biotechnology company's stock aftNovember 11, 2024 | marketbeat.comMerus (NASDAQ:MRUS) Given Consensus Recommendation of "Buy" by BrokeragesShares of Merus (NASDAQ:MRUS - Get Free Report) have been assigned a consensus rating of "Buy" from the thirteen ratings firms that are currently covering the stock, MarketBeat.com reports. Eleven research analysts have rated the stock with a buy rating and two have given a strong buy rating to thNovember 8, 2024 | marketbeat.comStrategic Buy Rating for Merus Amid Procedural Delays: A Long-Term Confidence in Pipeline PotentialNovember 7, 2024 | markets.businessinsider.comPositive Outlook for Merus: Buy Rating Affirmed Amid Manageable Challenges and Strong Growth PotentialNovember 7, 2024 | markets.businessinsider.comMerus to Present at Upcoming Investor ConferencesNovember 6, 2024 | globenewswire.comMerus (NASDAQ:MRUS) Shares Gap Down - Here's WhyMerus (NASDAQ:MRUS) Shares Gap Down - What's Next?November 5, 2024 | marketbeat.comMerus: Petosemtamab Set Up For December 2024 Data PresentationNovember 5, 2024 | seekingalpha.comMerus: FDA Extends Review of Cancer Drug Zenocutuzumab to FebruaryNovember 5, 2024 | marketwatch.comMerus’s Promising Pipeline and Financial Strength Support Buy RatingNovember 5, 2024 | markets.businessinsider.comMerus Receives FDA extension of PDUFA for zenocutuzumabNovember 5, 2024 | globenewswire.comHarbor Capital Advisors Inc. Makes New Investment in Merus (NASDAQ:MRUS)Harbor Capital Advisors Inc. acquired a new stake in shares of Merus (NASDAQ:MRUS - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The fund acquired 42,287 shares of the biotechnology company's stock, valued at approximately $2,113,000. Harbor Capital ANovember 5, 2024 | marketbeat.comabrdn plc Acquires Shares of 87,215 Merus (NASDAQ:MRUS)abrdn plc bought a new position in shares of Merus (NASDAQ:MRUS - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 87,215 shares of the biotechnology company's stock, valued at approximately $4,357,000.November 4, 2024 | marketbeat.comMerus Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsNovember 2, 2024 | finance.yahoo.comMerus Gains ‘Buy’ Rating: Strategic Advancements and Promising Trials Drive Potential Market GrowthNovember 2, 2024 | markets.businessinsider.comMerus (MRUS) Gets a Buy from Stifel NicolausNovember 2, 2024 | markets.businessinsider.comMerus (NASDAQ:MRUS) Earns Buy Rating from Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and set a $85.00 price objective on shares of Merus in a research report on Friday.November 1, 2024 | marketbeat.comMerus reports Q3 EPS ($1.46), consensus (88c)October 31, 2024 | msn.comPromising Clinical Trials Drive Buy Recommendation for Merus Amid Strong Phase II ResultsOctober 31, 2024 | markets.businessinsider.comMerus’s Strategic Trials and Pipeline Expansion Justify Buy Rating Despite Earnings MissOctober 31, 2024 | markets.businessinsider.comMerus Announces Financial Results for the Third Quarter 2024 and Provides Business UpdateOctober 31, 2024 | globenewswire.comNovo Holdings A S Purchases 25,000 Shares of Merus (NASDAQ:MRUS)Novo Holdings A S raised its holdings in shares of Merus (NASDAQ:MRUS - Free Report) by 3.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 700,000 shares of the biotechnology company's stock after acquiOctober 27, 2024 | marketbeat.comMerus initiated with a Buy at UBSOctober 24, 2024 | markets.businessinsider.comMoody Aldrich Partners LLC Invests $1.53 Million in Merus (NASDAQ:MRUS)Moody Aldrich Partners LLC bought a new stake in shares of Merus (NASDAQ:MRUS - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 30,571 shares of the biotechnology comOctober 24, 2024 | marketbeat.comMerus (NASDAQ:MRUS) Now Covered by UBS GroupUBS Group initiated coverage on shares of Merus in a research note on Thursday. They issued a "buy" rating and a $72.00 price objective for the company.October 24, 2024 | marketbeat.comInvesting in Merus (NASDAQ:MRUS) five years ago would have delivered you a 227% gainOctober 17, 2024 | finance.yahoo.comBuy Rating Affirmed for Merus with Promising Outlook on Petosemtamab’s Clinical and Market PotentialOctober 11, 2024 | markets.businessinsider.comMillennium Management LLC Has $14.39 Million Stock Position in Merus (NASDAQ:MRUS)Millennium Management LLC grew its holdings in shares of Merus (NASDAQ:MRUS - Free Report) by 61.9% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 243,257 shares of the biotechnology compOctober 7, 2024 | marketbeat.comBuy Rating Affirmed for Merus on Strong Clinical Trial Progress and Competitive PositioningOctober 1, 2024 | markets.businessinsider.comMerus (NASDAQ:MRUS) Price Target Raised to $111.00 at GuggenheimGuggenheim lifted their target price on Merus from $93.00 to $111.00 and gave the stock a "buy" rating in a research report on Tuesday.October 1, 2024 | marketbeat.comMerus Announces First Patient Dosed in LiGeR-HN1, a Phase 3 Trial Evaluating Petosemtamab in Combination with Pembrolizumab in 1L r/m HNSCCSeptember 30, 2024 | finance.yahoo.com675,000 Shares in Merus (NASDAQ:MRUS) Purchased by Novo Holdings A SNovo Holdings A S bought a new position in shares of Merus (NASDAQ:MRUS - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 675,000 shares of the biotechnology company's stock, valued at approximately $September 30, 2024 | marketbeat.comBOXER CAPITAL, LLC Acquires New Stake in Instil Bio IncSeptember 29, 2024 | finance.yahoo.comMerus (NASDAQ:MRUS) Shares Acquired by Algert Global LLCAlgert Global LLC grew its holdings in Merus (NASDAQ:MRUS - Free Report) by 36.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 133,323 shares of the biotechnology company's stock after purchasing an addiSeptember 29, 2024 | marketbeat.comMerus (NASDAQ:MRUS) Shares Bought by Driehaus Capital Management LLCDriehaus Capital Management LLC boosted its stake in shares of Merus (NASDAQ:MRUS - Free Report) by 26.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,550,009 shares of the biotechnology company'sSeptember 28, 2024 | marketbeat.comMerus (NASDAQ:MRUS) Shares Bought by Fred Alger Management LLCFred Alger Management LLC lifted its position in shares of Merus (NASDAQ:MRUS - Free Report) by 205.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 62,816 shares of the biotechnology company's stSeptember 27, 2024 | marketbeat.comMerus (NASDAQ:MRUS) is Deerfield Management Company L.P. Series C's 7th Largest PositionDeerfield Management Company L.P. Series C boosted its holdings in Merus (NASDAQ:MRUS - Free Report) by 3.8% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,749,401 shares of the biotechnology company's stock after purchasing an additional 100,000September 26, 2024 | marketbeat.comAffinity Asset Advisors LLC Makes New Investment in Merus (NASDAQ:MRUS)Affinity Asset Advisors LLC purchased a new position in shares of Merus (NASDAQ:MRUS - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 125,000 shares of the biotechnology companSeptember 25, 2024 | marketbeat.comGreat Point Partners LLC Increases Stake in Merus (NASDAQ:MRUS)Great Point Partners LLC raised its holdings in shares of Merus (NASDAQ:MRUS - Free Report) by 134.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 523,288 shares of the biotechnology company's stock after purchasing aSeptember 24, 2024 | marketbeat.comMerus (NASDAQ:MRUS) Shares Bought by Tri Locum Partners LPTri Locum Partners LP grew its holdings in Merus (NASDAQ:MRUS - Free Report) by 17.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 335,514 shares of the biotechnology company's stock after acquiring an additional 49,192 sharSeptember 23, 2024 | marketbeat.comAlly Bridge Group NY LLC Lowers Holdings in Merus (NASDAQ:MRUS)Ally Bridge Group NY LLC reduced its holdings in shares of Merus (NASDAQ:MRUS - Free Report) by 31.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 174,844 shares of the biotechnology company's stockSeptember 23, 2024 | marketbeat.comSeven Eight Capital LP Takes Position in Merus (NASDAQ:MRUS)Seven Eight Capital LP bought a new position in shares of Merus (NASDAQ:MRUS - Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 23,635 shares of the biotechnology company's stock, valued at approximately $September 20, 2024 | marketbeat.comTimesSquare Capital Management U.S. Small Cap Growth Strategy Established a Position in Merus N.V. (MRUS)September 18, 2024 | msn.comMerus N.V.: Merus Announces Abstract Accepted for Presentation at the ESMO Asia Congress 2024September 17, 2024 | finanznachrichten.deBuy Rating for Merus Affirmed by Analyst Andrew Berens on Strong Oncology Trial Results and Strategic ManagementSeptember 17, 2024 | markets.businessinsider.comMerus NV (MRUS): Short Seller Sentiment is Bearish on This Cancer StockSeptember 15, 2024 | msn.comFederated Hermes Inc. Has $141.94 Million Stock Position in Merus (NASDAQ:MRUS)Federated Hermes Inc. grew its position in Merus (NASDAQ:MRUS - Free Report) by 6.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,398,800 shares of the biotechnology company's stock after purchasing anSeptember 13, 2024 | marketbeat.com80,503 Shares in Merus (NASDAQ:MRUS) Bought by Nicholas Investment Partners LPNicholas Investment Partners LP purchased a new position in Merus (NASDAQ:MRUS - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 80,503 shares of the biotechnology company's stock, valuSeptember 12, 2024 | marketbeat.comTD Asset Management Inc Reduces Holdings in Merus (NASDAQ:MRUS)TD Asset Management Inc trimmed its stake in Merus (NASDAQ:MRUS - Free Report) by 15.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 127,554 shares of the biotechnology company's stock after selling 23,620 shaSeptember 11, 2024 | marketbeat.comMerus (NASDAQ:MRUS) Share Price Crosses Below Fifty Day Moving Average of $53.16Merus (NASDAQ:MRUS) Stock Passes Below 50-Day Moving Average of $53.16September 7, 2024 | marketbeat.com Get Merus News Delivered to You Automatically Sign up to receive the latest news and ratings for MRUS and its competitors with MarketBeat's FREE daily newsletter. Email Address The only candlestick pattern worth a darn (Ad)It’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again… Follow this link here and enter your email address to sign up… MRUS Media Mentions By Week MRUS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRUS News Sentiment▼1.380.55▲Average Medical News Sentiment MRUS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRUS Articles This Week▼34▲MRUS Articles Average Week Get Merus News Delivered to You Automatically Sign up to receive the latest news and ratings for MRUS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Viatris News Today Vaxcyte News Today Sarepta Therapeutics News Today Catalent News Today Qiagen News Today Revolution Medicines News Today Intra-Cellular Therapies News Today Roivant Sciences News Today Legend Biotech News Today Lantheus News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRUS) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merus Please log in to your account or sign up in order to add this asset to your watchlist. Share Merus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MRUS Stock Alerts